HYENA detects oncogenes activated by distal enhancers in cancer

Anqi Yu1, Ali E Yesilkanal1, Ashish Thakur2

  • 1Ben May Department for Cancer Research, University of Chicago, Chicago IL, USA.

Insights

Structural variations in cancer genomes can activate oncogenes. Our study identifies novel oncogenes, including non-coding genes, driven by enhancer hijacking, revealing new cancer mechanisms.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Somatic structural variations (SVs) can alter genome organization and gene expression in cancer.
  • Enhancer hijacking, a mechanism where SVs relocate enhancers to activate proto-oncogenes, has primarily focused on protein-coding genes.
  • Understanding SV-driven oncogene activation is crucial for cancer research.

Approach:

  • Developed HYENA, a computational algorithm to identify candidate oncogenes (protein-coding and non-coding) activated by enhancer hijacking.
  • Utilized tumor whole-genome and transcriptome sequencing data from 1,146 tumors across 25 adult cancer types.
  • Employed a rank-based regression model to link elevated gene expression with somatic SVs.

Key Points:

  • Identified 108 candidate oncogenes, including numerous non-coding genes, activated by enhancer hijacking.
  • Discovered that the long non-coding RNA TOB1-AS1 is activated by SVs in 10% of pancreatic cancers via altered 3D genome structure.
  • Demonstrated that high TOB1-AS1 expression promotes cell invasion and metastasis.

Conclusions:

  • HYENA expands the scope of enhancer hijacking studies to include non-coding genes.
  • Genetic alterations in non-coding regions significantly contribute to tumorigenesis and cancer progression.
  • This work provides new insights into the role of SVs and non-coding elements in cancer development.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K